Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Brown (N) Group Plc
-
Alm. Brand A/S – Weekly report on share buybacks
-
Data on debtor composition
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
AS Silvano Fashion Group Taxonomy report
-
The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
-
Preliminary data on early redemptions (prepayments)
-
Sydbank share buyback programme: transactions in week 51
-
Share buyback programme - week 51
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
VINCI awarded a contract to upgrade and extend wastewater treatment facilities in Canberra, Australia
-
Harmonisation of the articles of the group's Estonian subsidiaries
-
Form 8.5 (EPT/RI)-De La Rue plc
-
Šiaulių bankas to invest additional €60 million to finance the renovation of multi-apartment buildings in Lithuania
-
Announcement of drawings (CK95) - Nykredit Realkredit A/S
-
Falcon Oil & Gas Ltd. - Drilling completed on the second well in the Shenandoah South Pilot Project, Shenandoah S2-4H
-
Falcon Oil & Gas Ltd. - Change of Auditors
-
MaxCyte Announces Retirement of Board Member Art Mandell
-
Equinor ASA: Share buy-back
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 7)
-
Falcon Oil & Gas Ltd. - Drilling completed on the second well in the Shenandoah South Pilot Project, Shenandoah S2-4H
-
Financing facility update
-
Transaction in own shares
-
Falcon Oil & Gas Ltd. - Change of Auditors
-
Kitron signs contract for marine IoT technology
-
Information on audited Financial statements for the nine month period as at 30th of September of 2024
-
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics
-
Start of Day Message
-
Fagron updates on FDA communication regarding the June 2024 inspection at Wichita
-
Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis
-
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
-
Information release calendar for 2025
-
New Repeat Orders for QUADRA High-Throughput Metrology System from Leading Semiconductor Manufacturer fills up Nearfield Instruments’ 2025 Order Book
-
Alaska Permanent Capital Management to be acquired by holding company, Blue Umbrella, LLC
-
SYM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Symbotic Inc. - Contact Kessler Topaz Meltzer & Check, LLP
-
PACS Group, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds PACS Group, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
-
WOLF Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Wolfspeed, Inc.
-
Girls in Madagascar Learn Languages with Support from FunEasyLearn and Time + Tide Foundation
-
CoinEx 7th Anniversary CEO Open Letter: Seven Years Together, Creating the Future
-
Budpop’s Christmas Special Offer: 30% Off Sitewide with BUDSMAS30
-
Exhale Wellness Christmas Offer: Get 30% Off Sitewide
-
Bill Yarborough Announces His Debut Novel "Memories of MK-ULTRA: A Journey of Discovery from Darkness to Deliverance"
-
Dr. Yorell Manon Matos Launches Transformative Healthcare Education Grant to Cultivate Next Generation of Medical Innovators
-
Dr. Kent Scheff Announces the Launch of the Dr. Kent Scheff Scholarship for Sports Medicine
-
Now Streaming: Heritage Choir and Orchestra 2024 Christmas Concert
-
Sun Country Airlines Debuts First Ever Custom Aircraft Livery Celebrating Minnesota Golden Gopher Athletics
-
President Biden Signs Law to Deliver Funding to SBA to Reopen its Disaster Loan Program and Support Recovery in Communities across the Country
-
Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
-
NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections

